GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glycorex Transplantation AB (NGM:GTAB B) » Definitions » Gross Margin %

Glycorex Transplantation AB (NGM:GTAB B) Gross Margin % : 86.50% (As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Glycorex Transplantation AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Glycorex Transplantation AB's Gross Profit for the three months ended in Mar. 2025 was kr8.37 Mil. Glycorex Transplantation AB's Revenue for the three months ended in Mar. 2025 was kr9.68 Mil. Therefore, Glycorex Transplantation AB's Gross Margin % for the quarter that ended in Mar. 2025 was 86.50%.

Warning Sign:

Glycorex Transplantation AB gross margin has been in long-term decline. The average rate of decline per year is -3.3%.


The historical rank and industry rank for Glycorex Transplantation AB's Gross Margin % or its related term are showing as below:

NGM:GTAB B' s Gross Margin % Range Over the Past 10 Years
Min: 80.28   Med: 94.34   Max: 101.6
Current: 80.88


During the past 13 years, the highest Gross Margin % of Glycorex Transplantation AB was 101.60%. The lowest was 80.28%. And the median was 94.34%.

NGM:GTAB B's Gross Margin % is ranked better than
74.49% of 737 companies
in the Biotechnology industry
Industry Median: 60.69 vs NGM:GTAB B: 80.88

Glycorex Transplantation AB had a gross margin of 86.50% for the quarter that ended in Mar. 2025 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Glycorex Transplantation AB was -3.30% per year.


Glycorex Transplantation AB Gross Margin % Historical Data

The historical data trend for Glycorex Transplantation AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glycorex Transplantation AB Gross Margin % Chart

Glycorex Transplantation AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 91.22 88.43 87.34 89.63 80.28

Glycorex Transplantation AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 84.97 81.59 74.05 79.94 86.50

Competitive Comparison of Glycorex Transplantation AB's Gross Margin %

For the Biotechnology subindustry, Glycorex Transplantation AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glycorex Transplantation AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glycorex Transplantation AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Glycorex Transplantation AB's Gross Margin % falls into.


;
;

Glycorex Transplantation AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Glycorex Transplantation AB's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=28.2 / 35.159
=(Revenue - Cost of Goods Sold) / Revenue
=(35.159 - 6.935) / 35.159
=80.28 %

Glycorex Transplantation AB's Gross Margin for the quarter that ended in Mar. 2025 is calculated as


Gross Margin % (Q: Mar. 2025 )=Gross Profit (Q: Mar. 2025 ) / Revenue (Q: Mar. 2025 )
=8.4 / 9.681
=(Revenue - Cost of Goods Sold) / Revenue
=(9.681 - 1.307) / 9.681
=86.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Glycorex Transplantation AB  (NGM:GTAB B) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Glycorex Transplantation AB had a gross margin of 86.50% for the quarter that ended in Mar. 2025 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Glycorex Transplantation AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Glycorex Transplantation AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glycorex Transplantation AB Business Description

Traded in Other Exchanges
Address
Solvegatan 41, Lund, SWE, 223 70
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.

Glycorex Transplantation AB Headlines

No Headlines